Related Experiment Videos
[Cerebrospinal fluid pleiocytosis in multiple sclerosis]
J C Turpin1, N Delasnerie-Lauprêtre
1Service de Neurologie, Centre Hospitalier Régional et Universitaire de Reims, Hôpital Robert-Debré, France.
Pathologie-Biologie
|June 1, 1988
Summary
Cerebrospinal fluid (CSF) pleocytosis, an increased white blood cell count, does not indicate severity in multiple sclerosis (MS). This finding was observed in recent MS disease among young adult patients.
Area of Science:
- Neurology
- Immunology
- Clinical Research
Context:
- Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Cerebrospinal fluid (CSF) analysis is a key diagnostic tool in MS.
- CSF pleocytosis, an elevated cell count, is a common finding in MS.
Purpose:
- To investigate the relationship between CSF pleocytosis and disease severity in multiple sclerosis.
- To determine if CSF pleocytosis serves as a reliable index for MS disease severity.
Summary:
- A comparative study analyzed 100 MS patients with CSF pleocytosis ( > 2 cells/mm³) and 100 MS patients with normal CSF cell counts ( < 2 cells/mm³).
- The study found that CSF pleocytosis is not a reliable indicator of multiple sclerosis severity.
- Pleiocytosis was notably observed in recent-onset MS in young adult patients.
Impact:
- This research clarifies the diagnostic significance of CSF pleocytosis in MS.
- Findings suggest that pleocytosis in early MS may reflect acute inflammatory processes rather than long-term disease progression.
- Provides valuable insights for clinicians in interpreting CSF findings for MS patients.